©The Author(s) 2019.
World J Nephrol. Oct 27, 2019; 8(6): 95-108
Published online Oct 27, 2019. doi: 10.5527/wjn.v8.i6.95
Published online Oct 27, 2019. doi: 10.5527/wjn.v8.i6.95
Table 3 Infectious complications
| ABO-incompatible (n = 27) | ABO-compatible (n = 108) | P value | ||
| Total no. of infectious complications per patient | 1.7 (1-2.3) | 1.0 (0-2) | 0.004 | |
| CMV infections, (%) | 12 | 11 | ||
| EBV infections, (%) | 0 | 3 | ||
| BK infections, (%) | 15 | 6 | ||
| Other viral infections, (%) | 31 | 9 | ||
| First urinary tract infection, (%) | 38 | 30 | ||
| Recurrent urinary tract infections, (%) | 8 | 11 | ||
| Other bacterial infections, (%) | 23 | 7 | ||
| Other infections, not otherwise specified, (%) | 31 | 20 | ||
- Citation: van Sandwijk MS, Klooster A, ten Berge IJ, Diepstra A, Florquin S, Hoelbeek JJ, Bemelman FJ, Sanders JS. Complement activation and long-term graft function in ABO-incompatible kidney transplantation. World J Nephrol 2019; 8(6): 95-108
- URL: https://www.wjgnet.com/2220-6124/full/v8/i6/95.htm
- DOI: https://dx.doi.org/10.5527/wjn.v8.i6.95